Search results
Showing 16 to 30 of 179 results for physiotherapy
The STAK tool for preventing and treating knee stiffness (MIB252)
NICE has developed a medtech innovation briefing (MIB) on the STAK tool for preventing and treating knee stiffness .
This quality standard covers diagnosing, assessing and managing cerebral palsy in children and young people under 25. It describes high-quality care in priority areas for improvement.
View quality statements for QS162Show all sections
Sections for QS162
- Quality statements
- Quality statement 1: Follow-up for children with major risk factors for cerebral palsy
- Quality statement 2: Referral for children with delayed motor milestones
- Quality statement 3: Information for parents and carers of children and young people with cerebral palsy
- Quality statement 4: Personal folders for children and young people with cerebral palsy
- About this quality standard
Emergency and acute medical care in over 16s: service delivery and organisation (NG94)
This guideline covers organising and delivering emergency and acute medical care for people aged over 16 in the community and in hospital. It aims to reduce the need for hospital admissions by giving advanced training to paramedics and providing community alternatives to hospital care. It also promotes good-quality care in hospital and joint working between health and social services.
Path Finder for freezing of gait in people with Parkinson's disease (MIB170)
NICE has developed a medtech innovation briefing (MIB) on Path Finder for freezing of gait in people with Parkinson’s disease .
NICE has developed a medtech innovation briefing (MIB) on The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs .
complications? 6 Non-surgical options These include: : Specialist pelvic health physiotherapy. Physiotherapists working in different...
This guideline covers care and support for adults with cerebral palsy. It aims to improve health and wellbeing, promote access to services and support participation and independent living.
Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]
In development [GID-TA11373] Expected publication date: TBC
education to people with knee osteoarthritis who have been referred to physiotherapy by their GP. After attending, 77% of people were...
complications? 7 Non-surgical options These include: : Specialist pelvic health physiotherapy. Physiotherapists working in different...
What is the clinical and cost effectiveness of additional intensive physiotherapy and/or occupational therapy (for example, progressive...
NICE has developed a medtech innovation briefing (MIB) on ReStore Soft Exo-Suit for gait rehabilitation .
Omaveloxolone for treating Friedreich's ataxia in people 16 years and over ID6423
In development [GID-TA11431] Expected publication date: 13 August 2025
In development [GID-TA11430] Expected publication date: 21 August 2025
Evidence-based recommendations on velmanase alfa (Lamzede) for treating alpha-mannosidosis in people under 18 years and in people who turn 18 while on treatment.